Evidence map›Paper›PMID 40944608›Full record

ArticleBiopolymers2025

Advanced Biomaterial for Dual-Drug Release: A Hydrogel-Microparticle Approach.

Jose Gregorio Fontainez Garrido, Newton Andreo Filho, Fabiana Perrechil, Mariana Agostini de Moraes

Abstract read
In one paragraph

Article in Biopolymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jose Gregorio Fontainez GarridoDepartment of Chemical Engineering, Federal University of São Paulo-UNIFESP, Diadema, Brazil.
Newton Andreo FilhoDepartment of Pharmaceutical Science, Federal University of São Paulo-UNIFESP, Diadema, Brazil.ORCID https://orcid.org/0000-0002-9431-3088
Fabiana PerrechilDepartment of Chemical Engineering, Federal University of São Paulo-UNIFESP, Diadema, Brazil.ORCID https://orcid.org/0000-0001-7543-3837
Mariana Agostini de MoraesDepartment of Chemical Engineering, Federal University of São Paulo-UNIFESP, Diadema, Brazil.ORCID https://orcid.org/0000-0002-2586-6834

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 308994/2017-5Coordenação de Aperfeiçoamento de Pessoal de Nível Superior finance code 001Fundação de Amparo à Pesquisa do Estado de São Paulo 2018/15539-6Fundação de Amparo à Pesquisa do Estado de São Paulo 2019/08975-7
6 · The paper itself

Abstract

Advanced biomaterials with dual drug delivery represent a promising strategy to enhance therapeutic outcomes in wound treatment. This work aimed to combine antimicrobial and analgesic actions in a single platform, enabling the simultaneous release of both drugs from an advanced dual-drug delivery system based on a combined hydrogel and microparticle approach. The system was composed of alginate microparticles containing the antibiotic gentamicin incorporated into a gellan gum/collagen hydrogel matrix, in which the local anesthetic bupivacaine was directly loaded. The resulting composite was thoroughly characterized in terms of its morphological, physicochemical, mechanical, rheological, and thermal properties, as well as drug release profiles. The incorporation of microparticles significantly influenced the structural and functional behavior of the hydrogel, particularly at higher microparticle concentrations (50% w/v). Notably, the microparticles played a crucial role in maintaining the hydrogel's integrity in the presence of both drugs and enabled their controlled and simultaneous release, with each exhibiting distinct release kinetics. These findings highlight the potential of this hydrogel and microparticle composite as an advanced material for wound dressings, capable of promoting healing while simultaneously providing localized pain relief.

Indexed as

Biocompatible MaterialsDrug CarriersHydrogelsAlginatesAnti-Bacterial AgentsBupivacaineCollagenDrug Delivery SystemsDrug LiberationGentamicinsGlucuronic AcidHexuronic AcidsMicrospheresPolysaccharides, BacterialAlginatesAnti-Bacterial AgentsBiocompatible MaterialsBupivacaineCollagenDrug Carriersgellan gumGentamicinsGlucuronic AcidHexuronic AcidsHydrogelsPolysaccharides, Bacterialbiopolymerscontrolled releasedual‐drug deliveryhydrogelmicroparticlespolysaccharideswound healing

Identifiers

PMID40944608
PMCPMC12433186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.